Menu Search
Equities

Dynavax Technologies Corp

DVAX:NSQ

Dynavax Technologies Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)13.50
  • Today's Change-0.16 / -1.17%
  • Shares traded3.18m
  • 1 Year change+2.27%
  • Beta1.3515
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Dynavax Technologies Corp's revenues fell -67.86% from 722.68m to 232.28m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 293.16m to a loss of 6.39m.
Gross margin82.85%
Net profit margin7.85%
Operating margin-4.21%
Return on assets2.01%
Return on equity3.18%
Return on investment2.14%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Dynavax Technologies Corp fell by 51.66m. However, the company earned 100.56m from its operations for a Cash Flow Margin of 43.29%. In addition the company generated 1.39m cash from financing while 153.93m was spent on investing.
Cash flow per share0.176
Price/Cash flow per share71.50
Book value per share5.19
Tangible book value per share5.17
More ▼

Balance sheet in USDView more

Dynavax Technologies Corp has a Debt to Total Capital ratio of 24.70%, a lower figure than the previous year's 36.77%.
Current ratio13.23
Quick ratio12.34
Total debt/total equity0.3281
Total debt/total capital0.247
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.